Clinical Trial Update: A Safety Study in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 safety study in participants with advanced solid tumors has been terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Snippet

Sponsor: Eli Lilly and Company | Conditions: Advanced Solid Tumors | Phase 1 | Status: TERMINATED | Results posted: 2018-10-16